ELAVL1 and ovarian carcinoma: Another interaction with ovarian cancer involves miR-519, which targets the 3′-UTR of ELAVL1 mRNA, inhibiting its translation and slowing cell division of A2780 cells, a human ovarian cancer cell line, in vitro (Abdelmohsen et al., 2008).